Small Molecules

27 Mar 2007 JANUVIA(TM) Approved in the European Union for the Treatment of Type 2 Diabetes
27 Mar 2007 Momenta Pharmaceuticals Presents Preclinical Data for Novel Anticoagulant M118 At American College of Cardiology
27 Mar 2007 Clinical Data Completes Phase III Enrollment of Vilazodone for Depression
27 Mar 2007 HRA Pharma commences UK-based Phase III trial of Ella(R), a second-generation emergency contraceptive
27 Mar 2007 CombinatoRx, Incorporated (CRXX) Says Arthritis Drug Misses Primary Endpoint; Stock Falls
27 Mar 2007 Cephalon, Inc. (CEPH) Files Marketing Application for Approval of a Fentanyl Effervescent Buccal Tablet in Europe
26 Mar 2007 First Study To Show Positive Benefit On Atherosclerosis For People With Early Signs Of Diseased Arteries
26 Mar 2007 KAI Pharmaceuticals Presents Encouraging Phase 1/2 Results of a Novel Treatment for Heart Attack
25 Mar 2007 Schering-Plough's Novel Oral Thrombin Receptor Antagonist Meets Primary Endpoint in Phase II Trial
24 Mar 2007 Oral Cancer Drug REVLIMID(R) Receives Positive Opinion for Treatment of Multiple Myeloma From European Medicines Agency
24 Mar 2007 NovaDel's European Formulation of Ondansetron Targeted for U.S. Zensana(TM)
24 Mar 2007 Hana Biosciences Provides Pipeline Update
24 Mar 2007 Advancis Pharmaceutical Corporation (AVNC) Resubmits New Drug Application for Once-Daily Amoxicillin PULSYS
23 Mar 2007 Satraplatin Phase 3 SPARC Trial - Additional Data Presented at European Association of Urology Congress
23 Mar 2007 Xanthus Initiates a Phase 1 Study of Clomet for Treatment of Solid Tumors
23 Mar 2007 Cubist Pharmaceuticals Licenses Rights for Development and Commercialization of CUBICIN in Japan to Merck & Co., Inc.
23 Mar 2007 POZEN Announces Trexima(TM) (Sumatriptan Succinate and Naproxen Sodium) Amended Response Accepted for Review by FDA
23 Mar 2007 Aeolus Pharmaceuticals Announces Successful Completion of Multiple Dose Safety Study of AEOL 10150
22 Mar 2007 Evotec Initiates its First Phase I Clinical Study with EVT 302
22 Mar 2007 Amicus Therapeutics Presents Positive Results From Phase 1 Clinical Studies of Plicera(TM) for Gaucher Disease
22 Mar 2007 Encysive Pharmaceuticals Announces Patient Enrollment Initiated for TBC3711 Phase II Study
22 Mar 2007 Avicena Announces Patient Enrollment in National Institutes of Health (NIH) Phase III Parkinson's Disease Trial
22 Mar 2007 POZEN Announces Trexima(TM) (Sumatriptan Succinate and Naproxen Sodium) Amended Response Accepted for Review by FDA
21 Mar 2007 MGI PHARMA Announces Positive Results from a Pivotal Phase 3 Study of Aquavan(R) Injection in Patients Undergoing Bronchoscopy
21 Mar 2007 Abraxis BioScience to Initiate Two Phase I/II Clinical Trials with nab-docetaxel in Hormone Refractory Prostate and Metastatic Breast Cancer

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2022 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up